Sign in
Groups
Researchers
Results
HOSPITAL UNIVERSITARIO RUBER
Department
Université Catholique de Louvain
Louvain-la-Neuve, Bélgica
You are in
Collaborations
Université Catholique de Louvain
Publications in collaboration with researchers from Université Catholique de Louvain (2)
2022
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
Journal of Clinical Oncology, Vol. 32
2017
Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial
The Lancet Oncology, Vol. 18, Núm. 7, pp. 904-916
Contact
Legal notice
Help
translate
en
arrow_drop_down
translate
en
arrow_drop_down
es
ca
eu
gl
fr
de